111 (YI) Free Cash Flow Growth (3y) (2020 - 2025)
111 (YI) Free Cash Flow Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | -0.74% |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | 30.60% |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | 10.23% |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | -212.44% |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | -22.47% |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | -37.49% |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | -3.04% |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | -47.48% |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | 44.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -22.47% |
| Sep 30, 2025 | 45.50% |
| Jun 30, 2025 | -23.21% |
| Mar 31, 2025 | 50.94% |
| Dec 31, 2024 | 45.87% |
| Sep 30, 2024 | 42.96% |
| Jun 30, 2024 | 130.83% |
| Mar 31, 2024 | 33.49% |
| Dec 31, 2023 | -5.07% |
| Sep 30, 2023 | -58.34% |
| Jun 30, 2023 | -48.46% |
| Mar 31, 2023 | -3.27% |
| Dec 31, 2022 | -2.74% |
| Sep 30, 2022 | -65.00% |
| Jun 30, 2022 | 30.83% |
| Mar 31, 2022 | -7.01% |
| Dec 31, 2021 | -62.07% |
| Sep 30, 2021 | -39.04% |
| Jun 30, 2021 | 34.89% |
| Mar 31, 2021 | -132.30% |